SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLogistics Dev Regulatory News (LDG)

Share Price Information for Logistics Dev (LDG)

Share Price is delayed by 15 minutes
Get Live Data
13.75    0.00 (0.00%)
Bid:
13.50
Ask:
14.00
Spread: 0.50 (3.704%)
Market Cap: £56.90m
LDG Live PriceLast checked at - London Stock Exchange

Intraday Logistics Dev Share Chart

Form 8.3

14 May 2024 14:06

RNS Number : 4032O
DBAY Advisors Limited
14 May 2024
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

DBAY Advisors Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Pershing Nominees Ltd for Fixtaia Ltd and Logistics Development Group plc under the discretionary management of DBAY Advisors Limited.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Mission Group Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

14 May 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

1p Ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

9,905,107

10.74

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

9,905,107

10.74

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

10p Ordinary Shares

Sale

25,354

23.7122p

10p Ordinary Shares

Sale

14,539

23.8842p

10p Ordinary Shares

Sale

100,000

23.711p

10p Ordinary Shares

Sale

175,000

23.7512p

10p Ordinary Shares

Sale

120,000

23.8155p

10p Ordinary Shares

Sale

125,000

23.6845p

10p Ordinary Shares

Sale

200,000

24.056p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

14 May 2024

Contact name:

Michael Haxby

Telephone number*:

01624 602132

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETXZLFFZELBBBZ
Date   Source Headline
20th Apr 20237:00 amRNSTransaction in Own Shares
19th Apr 20237:00 amRNSTransaction in Own Shares
18th Apr 20237:00 amRNSTransaction in Own Shares
17th Apr 20237:00 amRNSTransaction in Own Shares
14th Apr 20237:00 amRNSTransaction in Own Shares
13th Apr 20237:00 amRNSTransaction in Own Shares
12th Apr 20231:37 pmRNSHolding(s) in Company
12th Apr 20237:00 amRNSTransaction in Own Shares
11th Apr 20237:00 amRNSTransaction in Own Shares
6th Apr 20237:00 amRNSTransaction in Own Shares
5th Apr 202311:00 amRNSNotification of Major Holdings
5th Apr 20237:00 amRNSTransaction in Own Shares
4th Apr 202311:18 amRNSCommencement of Share Buyback Programme
4th Apr 202310:46 amRNSNotification of Major Holdings
4th Apr 20237:00 amRNSPosting of Annual Report and Notice of AGM
31st Mar 20237:00 amRNSFinal Results for year ended 30 November 2022
29th Mar 20234:47 pmRNSHolding(s) in Company
29th Mar 20237:00 amRNSNotification of Major Holdings
29th Mar 20237:00 amRNSShare Capital Reduction
21st Mar 20234:59 pmRNSNotification of Major Holdings
21st Mar 20237:00 amRNSFurther Alliance Pharma plc Investment
14th Mar 20231:47 pmRNSNotification of Major Holdings
6th Mar 20232:23 pmRNSResults of General Meeting
23rd Feb 20236:19 pmRNSReplacement Further Alliance Pharma plc Investment
23rd Feb 20231:28 pmRNSFurther Alliance Pharma plc Investment
16th Feb 20237:00 amRNSCircular Publication and GM Notice
9th Feb 20237:00 amRNSFurther re Synsion Investment
3rd Feb 202312:21 pmRNSHolding(s) in Company
30th Jan 20235:18 pmRNSNotification of Major Holdings
16th Jan 20233:35 pmRNSNotification of Major Holdings
22nd Dec 202210:31 amRNSAlliance Pharma plc Investment
22nd Dec 20229:51 amRNSNotification of Major Holdings
19th Dec 202212:52 pmRNSHolding(s) in Company
8th Dec 20225:08 pmRNSHolding(s) in Company
5th Dec 20223:21 pmRNSHolding(s) in Company
1st Dec 20227:30 amRNSSynsion Investment and Intended Further Buyback
31st Oct 20229:41 amRNSHolding(s) in Company
24th Oct 20223:20 pmRNSFinsbury Food Group Investment - Update
24th Oct 202212:04 pmRNSHolding(s) in Company
20th Oct 20224:27 pmRNSHolding(s) in Company
18th Oct 20221:11 pmRNSHolding(s) in Company
18th Oct 20227:00 amRNSFinsbury Food Group Investment
5th Oct 20221:40 pmRNSHolding(s) in Company
5th Sep 202210:44 amRNSHolding(s) in Company
26th Aug 20227:00 amRNSInterim Results for six months ended 31 May 2022
28th Jun 20221:12 pmRNSHolding(s) in Company
28th Jun 20227:00 amRNSCareTech Update
27th Jun 20223:37 pmRNSHolding(s) in Company
12th May 20222:08 pmRNSResult of AGM
10th May 20221:19 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.